Evidence map›Paper›PMID 42012470›Full record

ArticleMicrobial genomics2026

Emergence of outbreak-driving high-risk

Chih-Ming Chen, Hui-Ling Tang, Se-Chin Ke, Yi-Pei Lin, Bo-Han Chen, Ru-Hsiou Teng, Chien-Shun Chiou, Min-Chi Lu, Yi-Chyi Lai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chih-Ming ChenDepartment of Internal Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, ROC.
Hui-Ling TangDepartment of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan, ROC.
Se-Chin KeInfection Control Office, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, ROC.
Yi-Pei LinDepartment of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan, ROC.
Bo-Han ChenCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan, ROC.
Ru-Hsiou TengCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan, ROC.
Chien-Shun ChiouCentral Region Laboratory, Center for Diagnostics and Vaccine Development, Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan, ROC.
Min-Chi LuDepartment of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan, ROC.
Yi-Chyi LaiDepartment of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, ROC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global rise of carbapenem-resistant

Indexed as

Pseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDisease OutbreaksDrug Resistance, Multiple, BacterialGenome, BacterialHumansMembrane Transport ProteinsMicrobial Sensitivity TestsPhylogenyTaiwanWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsMembrane Transport Proteinscarbapenem-resistant (CR)extensively drug-resistant (XDR)Pseudomonas aeruginosaST235*ST292VIM (Verona Integron-encoded Metallo-Beta-lactamase)-producing ST244

Identifiers

PMID42012470
PMCPMC13098761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.